Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe temporary NIH notice about website updates and the shift from “Artificial Intelligence” to “Super Intelligence” is no longer displayed above the error page.SummaryDifference1%

- Check21 days agoChange DetectedThe site revision changed from v3.7.2 to v3.8.0 in the footer; the study record remains inaccessible.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces NIH’s website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check35 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov page.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.